Related Experiment Video
Updated: Aug 7, 2026
09:01
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Hemostatic therapy for intracerebral hemorrhage
Current Atherosclerosis Reports
|July 11, 2006
Summary
Intracerebral hemorrhage (ICH) management has seen few advances. A phase II trial suggests recombinant activated factor VII may reduce ICH expansion, mortality, and disability if given early.
Area of Science:
- Neurology
- Critical Care Medicine
- Hematology
Background:
- Intracerebral hemorrhage (ICH) carries the highest mortality and morbidity among stroke types.
- Despite intensive care unit (ICU) supportive measures, specific therapies to improve ICH outcomes have been limited.
- Current management focuses on supportive care, including ventilatory support, blood pressure management, and intracranial pressure monitoring.
Purpose of the Study:
- To evaluate the efficacy of recombinant activated factor VII (rFVIIa) in reducing hematoma expansion and improving outcomes in patients with ICH.
- To assess the safety and effectiveness of early rFVIIa administration within 3 hours of ICH onset.
Main Methods:
- A phase II clinical trial was conducted to investigate the effects of rFVIIa on ICH.
- Patients received rFVIIa within 3 hours of symptom onset.
Main Results:
- Recombinant activated factor VII administration significantly reduced hematoma expansion.
- Early treatment with rFVIIa was associated with decreased mortality and disability rates.
- The findings suggest a potential new therapeutic option for acute ICH.
Conclusions:
- Recombinant activated factor VII shows promise as a treatment for intracerebral hemorrhage.
- Further investigation in a phase III trial is warranted to confirm these beneficial effects.
- Early intervention with rFVIIa may represent a significant advancement in managing ICH.
Related Concept Videos
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...